BRAINSTORM CELL THERAPEUTICS INC. AWARD AGREEMENT FOR RESTRICTED STOCK UNITS GRANTED UNDER SECTION 102(b)(2) OF THE ISRAELI INCOME TAX ORDINANCE TO EMPLOYEES, OFFICERS OR DIRECTORS AS 102 CAPITAL GAINS TRACK GRANTAward Agreement for Restricted Stock Units • August 14th, 2024 • Brainstorm Cell Therapeutics Inc. • Biological products, (no disgnostic substances)
Contract Type FiledAugust 14th, 2024 Company IndustryThis Award Agreement (the “Agreement”) includes the Notice of Grant attached hereto as Exhibit A (the “Notice of Grant”), which is incorporated herein by reference and is made and entered into as of the Date of Grant shown in the Notice of Grant by and between Brainstorm Cell Therapeutics Inc. (the “Company”) and the Participant named in the Notice of Grant. Capitalized terms not defined in this Agreement shall have the meaning ascribed to them in the Plan.
BRAINSTORM CELL THERAPEUTICS INC. AWARD AGREEMENT FOR RESTRICTED STOCK UNITS GRANTED UNDER SECTION 102(b)(2) OF THE ISRAELI INCOME TAX ORDINANCE TO EMPLOYEES, OFFICERS OR DIRECTORS AS 102 CAPITAL GAINS TRACK GRANTAward Agreement for Restricted Stock Units • August 14th, 2024 • Brainstorm Cell Therapeutics Inc. • Biological products, (no disgnostic substances)
Contract Type FiledAugust 14th, 2024 Company IndustryThis Award Agreement (the “Agreement”) includes the Notice of Grant attached hereto as Exhibit A (the “Notice of Grant”), which is incorporated herein by reference and is made and entered into as of the Date of Grant shown in the Notice of Grant by and between Brainstorm Cell Therapeutics Inc. (the “Company”) and the Participant named in the Notice of Grant. Capitalized terms not defined in this Agreement shall have the meaning ascribed to them in the Plan.
BRAINSTORM CELL THERAPEUTICS INC. AWARD AGREEMENT FOR RESTRICTED STOCK UNITS GRANTED UNDER SECTION 102(b)(2) OF THE ISRAELI INCOME TAX ORDINANCE TO EMPLOYEES, OFFICERS OR DIRECTORS AS 102 CAPITAL GAINS TRACK GRANTAward Agreement for Restricted Stock Units • August 14th, 2024 • Brainstorm Cell Therapeutics Inc. • Biological products, (no disgnostic substances)
Contract Type FiledAugust 14th, 2024 Company IndustryThis Award Agreement (the “Agreement”) includes the Notice of Grant attached hereto as Exhibit A (the “Notice of Grant”), which is incorporated herein by reference and is made and entered into as of the Date of Grant shown in the Notice of Grant by and between Brainstorm Cell Therapeutics Inc. (the “Company”) and the Participant named in the Notice of Grant. Capitalized terms not defined in this Agreement shall have the meaning ascribed to them in the Plan.